These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23349487)

  • 21. Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice.
    Liu L; Wang F; Lu H; Ren X; Zou J
    Islets; 2014; 6(4):e962386. PubMed ID: 25437377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Islet Expression Levels of Prostaglandin E
    Truchan NA; Fenske RJ; Sandhu HK; Weeks AM; Patibandla C; Wancewicz B; Pabich S; Reuter A; Harrington JM; Brill AL; Peter DC; Nall R; Daniels M; Punt M; Kaiser CE; Cox ED; Ge Y; Davis DB; Kimple ME
    ACS Pharmacol Transl Sci; 2021 Aug; 4(4):1338-1348. PubMed ID: 34423270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bombesin receptor subtype-3 (BRS-3) regulates glucose-stimulated insulin secretion in pancreatic islets across multiple species.
    Feng Y; Guan XM; Li J; Metzger JM; Zhu Y; Juhl K; Zhang BB; Thornberry NA; Reitman ML; Zhou YP
    Endocrinology; 2011 Nov; 152(11):4106-15. PubMed ID: 21878513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon receptors on human islet cells contribute to glucose competence of insulin release.
    Huypens P; Ling Z; Pipeleers D; Schuit F
    Diabetologia; 2000 Aug; 43(8):1012-9. PubMed ID: 10990079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis.
    Tiano JP; Tate CR; Yang BS; DiMarchi R; Mauvais-Jarvis F
    Sci Rep; 2015 May; 5():10211. PubMed ID: 25970118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of the glucagon-like peptide-1 receptor does not affect the metabolic phenotype of mice with liver-specific G(s)α deficiency.
    Chen M; Mema E; Kelleher J; Nemechek N; Berger A; Wang J; Xie T; Gavrilova O; Drucker DJ; Weinstein LS
    Endocrinology; 2011 Sep; 152(9):3343-50. PubMed ID: 21771891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct effects of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist on islet morphology and function.
    Morita A; Mukai E; Hiratsuka A; Takatani T; Iwanaga T; Lee EY; Miki T
    Endocrine; 2016 Mar; 51(3):429-39. PubMed ID: 26349938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Function and expression of sulfonylurea, adrenergic, and glucagon-like peptide 1 receptors in isolated porcine islets.
    Kelly AC; Steyn LV; Kitzmann JP; Anderson MJ; Mueller KR; Hart NJ; Lynch RM; Papas KK; Limesand SW
    Xenotransplantation; 2014; 21(4):385-91. PubMed ID: 24801676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling.
    Nolan CJ; Leahy JL; Delghingaro-Augusto V; Moibi J; Soni K; Peyot ML; Fortier M; Guay C; Lamontagne J; Barbeau A; Przybytkowski E; Joly E; Masiello P; Wang S; Mitchell GA; Prentki M
    Diabetologia; 2006 Sep; 49(9):2120-30. PubMed ID: 16868750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
    Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
    J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posttranscriptional regulation of the prostaglandin E receptor spliced-isoform EP3-γ and its implication in pancreatic β-cell failure.
    Srivastava R; Horwitz M; Hershko-Moshe A; Bronstein S; Ben-Dov IZ; Melloul D
    FASEB J; 2023 Jun; 37(6):e22958. PubMed ID: 37171267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of imidazoline receptor I
    Amisten S; Duner P; Asplund O; Mohammed Al-Amily I; Groop L; Salehi A
    J Diabetes Complications; 2018 Sep; 32(9):813-818. PubMed ID: 29996974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epac2-dependent rap1 activation and the control of islet insulin secretion by glucagon-like peptide-1.
    Leech CA; Chepurny OG; Holz GG
    Vitam Horm; 2010; 84():279-302. PubMed ID: 21094904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
    Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
    Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotinic acid inhibits glucose-stimulated insulin secretion via the G protein-coupled receptor PUMA-G in murine islet β cells.
    Li HM; Zhang M; Xu ST; Li DZ; Zhu LY; Peng SW; Chen GQ; Martin PM; Ganapathy V; Wei CJ
    Pancreas; 2011 May; 40(4):615-21. PubMed ID: 21441844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
    Whalley NM; Pritchard LE; Smith DM; White A
    J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E(2) mediates inhibition of insulin secretion by interleukin-1beta.
    Tran PO; Gleason CE; Poitout V; Robertson RP
    J Biol Chem; 1999 Oct; 274(44):31245-8. PubMed ID: 10531320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced GLP-1- and sulfonylurea-induced insulin secretion in islets lacking leptin signaling.
    Morioka T; Dishinger JF; Reid KR; Liew CW; Zhang T; Inaba M; Kennedy RT; Kulkarni RN
    Mol Endocrinol; 2012 Jun; 26(6):967-76. PubMed ID: 22474124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of mammalian homologue of Caenorhabditis elegans unc-13-1 (Munc13-1) in the recruitment of newcomer insulin granules in both first and second phases of glucose-stimulated insulin secretion in mouse islets.
    Xie L; Zhu D; Gaisano HY
    Diabetologia; 2012 Oct; 55(10):2693-2702. PubMed ID: 22814762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.